COF
65
-4
CFG
89
-4
CSCO
60
-3
AMP
67
-3
AZO
42
-3
BRK.B
45
3
ADM
47
3
DAL
68
-2
APH
56
-2
APA
55
2
CAG
41
5
CB
67
2
BAC
72
-6
AA
70
-3
CMG
57
-6
BBY
43
-3
COP
44
4
ADI
71
-2
CNP
59
2
ACN
56
2
COF
65
-4
CFG
89
-4
CSCO
60
-3
AMP
67
-3
AZO
42
-3
BRK.B
45
3
ADM
47
3
DAL
68
-2
APH
56
-2
APA
55
2
CAG
41
5
CB
67
2
BAC
72
-6
AA
70
-3
CMG
57
-6
BBY
43
-3
COP
44
4
ADI
71
-2
CNP
59
2
ACN
56
2
Financhill
Back

Ovid Therapeutics, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Sell
28

OVID
Ovid Therapeutics, Inc.

Last Price:
$1.65
Seasonality Move:
-12.18%
Buy
57

LYEL
Lyell Immunopharma, Inc.

Last Price:
$36.08
Seasonality Move:
-22.7%
Sell
28
Ovid Therapeutics, Inc. (OVID) is a Sell

Is Ovid Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Ovid Therapeutics, Inc. [OVID] share price is $1.65. The Score for OVID is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • OVID is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $36.05. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

OVID Stock Price Chart

What is Ovid Therapeutics, Inc.'s stock price today?

  • The Ovid Therapeutics, Inc. share price today is $1.65
    The current trend is moderately bullish and OVID is experiencing slight selling pressure.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $36.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight buying pressure.

OVID Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 52.96 Buy
Chaikin Money Flow: -387295 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.48 - 1.74) Buy
Bollinger Bands (100): (1.09 - 1.67) Buy

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.11 Buy
Relative Strength Index (14 RSI): 67.85 Buy
Chaikin Money Flow: 30003 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.49 - 35.13) Buy
Bollinger Bands (100): (10.87 - 25.69) Buy

OVID Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.64 Buy
20-day SMA: 1.63 Buy
50-day SMA: 1.51 Buy
200-day SMA: 0.87 Buy
8-day EMA: 1.68 Sell
20-day EMA: 1.61 Buy
50-day EMA: 1.43 Buy
200-day EMA: 0.71 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.28 Buy
20-day SMA: 31 Buy
50-day SMA: 23.25 Buy
200-day SMA: 13.99 Buy
8-day EMA: 35.25 Buy
20-day EMA: 31.52 Buy
50-day EMA: 25.41 Buy
200-day EMA: 18.18 Buy

Ovid Therapeutics, Inc. Earnings Growth & OVID Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.08 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

Ovid Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):